| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | H79TI084938 | University of Louisiana at Monroe Harm Reduction Education and Referral for Opioid Overdose Reversal (ULM H.E.R.O) Program | 001 | 2 | SAMHSA | 3/21/2024 | $0 |
| | 2024 | 2023 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | CE152687 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/9/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | CE152687 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | H79TI084938 | University of Louisiana at Monroe Harm Reduction Education and Referral for Opioid Overdose Reversal (ULM H.E.R.O) Program | 000 | 2 | SAMHSA | 3/20/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,012,548 ) |
| | 2023 | 2023 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | H79TI084938 | University of Louisiana at Monroe Harm Reduction Education and Referral for Opioid Overdose Reversal (ULM H.E.R.O) Program | 002 | 2 | SAMHSA | 8/21/2023 | $604,593 |
| | 2023 | 2023 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | R01CA255176 | Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC | 000 | 3 | NIH | 3/25/2023 | $323,057 |
| | 2023 | 2023 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | R01CA255176 | Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC | 001 | 3 | NIH | 6/30/2023 | -$306,673 |
| | 2023 | 2023 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R21CA263290 | Targeting PCSK9 axis for castration-resistant prostate cancer recurrence suppression | 000 | 2 | NIH | 2/23/2023 | $161,499 |
| | 2023 | 2023 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | CE152687 | Community Project Funding/Congressionally Directed Spending - Construction | 00 | 1 | HRSA | 9/21/2023 | $504,987 |
| | 2023 | 2022 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | H79TI084938 | University of Louisiana at Monroe Harm Reduction Education and Referral for Opioid Overdose Reversal (ULM H.E.R.O) Program | 001 | 1 | SAMHSA | 4/25/2023 | $0 |
| | 2023 | 2022 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | H79TI084938 | University of Louisiana at Monroe Harm Reduction Education and Referral for Opioid Overdose Reversal (ULM H.E.R.O) Program | 000 | 1 | SAMHSA | 4/24/2023 | $0 |
| | 2023 | 2021 | University of Louisiana at Monroe | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | E1317721 | HPSL - Pharmacy | 002 | 2 | HRSA | 12/9/2022 | -$181,616 |
| | 2023 | 2021 | University of Louisiana at Monroe | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | E1317721 | HPSL - Pharmacy | 003 | 2 | HRSA | 8/2/2023 | $0 |
| | 2023 | 2020 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | R01DK109382 | Estradiol Regulation of Hypothalamic Astrocyte Glycogen | 000 | 5 | NIH | 4/7/2023 | -$1,048 |
| | 2023 | 2018 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | R15DK118515 | JAK/STAT signaling, peripheral insulin resistance, and pathogenesis in the high fat diet model of obesity in Drosophila melanogaster | 000 | 1 | NIH | 6/2/2023 | -$59,751 |
| | 2023 | 2018 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVENUE | MONROE | LA | 71209-9000 | OUACHITA | USA | R15DK118515 | JAK/STAT signaling, peripheral insulin resistance, and pathogenesis in the high fat diet model of obesity in Drosophila melanogaster | 000 | 1 | NIH | 6/2/2023 | -$32,500 |
|
| Issue Date FY: 2022 ( Subtotal = $2,167,105 ) |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | H79TI084938 | University of Louisiana at Monroe Harm Reduction Education and Referral for Opioid Overdose Reversal (ULM H.E.R.O) Program | 000 | 1 | SAMHSA | 7/29/2022 | $661,629 |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R01CA255176 | Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC | 001 | 2 | NIH | 3/17/2022 | $296,685 |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R01CA255176 | Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC | 002 | 2 | NIH | 5/23/2022 | $26,372 |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R21CA263290 | Targeting PCSK9 axis for castration-resistant prostate cancer recurrence suppression | 000 | 1 | NIH | 1/25/2022 | $182,419 |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | E4CHP46341 | NSL - Baccalaureate Nursing | 000 | 1 | HRSA | 7/26/2022 | $700,000 |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | E4DHP46450 | NSL - Graduate Nursing | 000 | 1 | HRSA | 8/3/2022 | $300,000 |
| | 2022 | 2021 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | E13HP17721 | HPSL - Pharmacy | 001 | 2 | HRSA | 12/2/2021 | $0 |
| | 2022 | 2021 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R01CA255176 | Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC | 000 | 1 | NIH | 2/15/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $511,267 ) |
| | 2021 | 2021 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | E1317721 | HPSL - Pharmacy | 000 | 2 | HRSA | 8/19/2021 | $181,616 |
| | 2021 | 2021 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R01CA255176 | Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC | 000 | 1 | NIH | 3/26/2021 | $329,651 |
|
| Issue Date FY: 2020 ( Subtotal = $352,405 ) |
| | 2020 | 2020 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R01DK109382 | Estradiol Regulation of Hypothalamic Astrocyte Glycogen | 000 | 5 | NIH | 7/14/2020 | $352,726 |
| | 2020 | 2019 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R01DK109382 | Estradiol Regulation of Hypothalamic Astrocyte Glycogen | 001 | 4 | NIH | 8/26/2020 | $0 |
| | 2020 | 2015 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R15CA188225 | Molecular mechanism of EGFR heterodimerization: inhibition by a peptidomimetic | 000 | 1 | NIH | 1/28/2020 | -$321 |
|
| Issue Date FY: 2019 ( Subtotal = $352,726 ) |
| | 2019 | 2019 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R01DK109382 | Estradiol Regulation of Hypothalamic Astrocyte Glycogen | 000 | 4 | NIH | 8/28/2019 | $352,726 |
|
| Issue Date FY: 2018 ( Subtotal = $701,195 ) |
| | 2018 | 2018 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R15DK118515 | JAK/STAT signaling, peripheral insulin resistance, and pathogenesis in the high fat diet model of obesity in Drosophila melanogaster | 000 | 1 | NIH | 9/20/2018 | $320,000 |
| | 2018 | 2018 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R01DK109382 | Estradiol Regulation of Hypothalamic Astrocyte Glycogen | 000 | 3 | NIH | 7/9/2018 | $352,726 |
| | 2018 | 2018 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R15DK118515 | JAK/STAT signaling, peripheral insulin resistance, and pathogenesis in the high fat diet model of obesity in Drosophila melanogaster | 000 | 1 | NIH | 9/20/2018 | $32,500 |
| | 2018 | 2016 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R21HD083389 | PIXE Spectrometric Mapping of Metabolic Pathway Input to GnRH Neurons | 000 | 2 | NIH | 5/9/2018 | -$4,031 |
| | 2018 | 2015 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R15NS091934 | Targeting cerebrovascular endothelial cells as a therapeutic approach for amyloid pathogenesis | 000 | 1 | NIH | 2/12/2018 | $0 |
| | 2018 | 2015 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R15CA188225 | Molecular mechanism of EGFR heterodimerization: inhibition by a peptidomimetic | 000 | 1 | NIH | 8/21/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $182,542 ) |
| | 2017 | 2017 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R01DK109382 | Estradiol Regulation of Hypothalamic Astrocyte Glycogen | 000 | 2 | NIH | 6/28/2017 | $352,726 |
| | 2017 | 2015 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R15CA188225 | Molecular mechanism of EGFR heterodimerization: inhibition by a peptidomimetic | 000 | 1 | NIH | 1/9/2017 | $0 |
| | 2017 | 2015 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R15NS091934 | Targeting cerebrovascular endothelial cells as a therapeutic approach for amyloid pathogenesis | 000 | 1 | NIH | 9/20/2017 | -$127,703 |
| | 2017 | 2013 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R15CA167476 | Ceramide glycosylation determines the stemness of cancer stem cells | 000 | 1 | NIH | 5/19/2017 | -$38,746 |
| | 2017 | 2013 | UNIVERSITY OF LOUISIANA AT MONROE | 700 UNIVERSITY AVE | MONROE | LA | 71209-9000 | OUACHITA | USA | R15CA167475 | Design of novel c-Met inhibitors inspired by olive phenolics | 000 | 1 | NIH | 5/19/2017 | -$3,735 |
|
| Issue Date FY: 2016 ( Subtotal = $512,832 ) (Continued on the next page) |
|
